News About: Pharm. Industry
Pfizer Korea unveils Norvasc ODTPfizer Korea, a Korean unit of the U.S. based Pfizer Inc., said Tuesday it has started selling the oral disintegrating tablets (5 mg, 10 mg) of Norvasc (amlodipine besylate) her...
|
Listed 55 pharmaceutical firms’ debts post 5.5 trillion won last year
Korea’s listed 55 drug firms’ debts stood at 5.53 trillion won last year, showing a slight increase from the previous year, an online business data provider said Monday.
In general, a high debt-to-equity ratio ind...
Korea emerging as global drug trial hub
Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research, experts claim.
“These clinical trials benefit Ko...
AstraZeneca Korea to launch ‘More Life’ campaign
AstraZeneca Korea said Monday it will launch a fund-raising campaign called ‘More Life’ through a talk show program to support, educate, and inspire those affected by acute coronary syndromes (ACS)
The company has ...
Drug makers seeking new growth engines
Local drug makers are scrambling to find new growth engines against a deteriorating business environment.
In their regular shareholders meetings on Friday, Korean drug makers vowed to spur efforts to go global and ...
Will pharmaceutical firms survive global giants’ onslaught?
Korean pharmaceutical companies are feeling pressure from all sides. Relying too much on selling cheap generic drugs instead of developing original drugs, they lack competitiveness to take on global players, according...
Ildong’s exclusive distribution of LGLS’s Factive in Korea
LG Life Sciences (LGLS) and Ildong Pharmaceutical announced Friday they have concluded an agreement that Ildong will exclusively distribute Factive (gemifloxacin), a synthetic broad-spectrum antibacterial agent for or...
Government to support Chong Kun Dang’s dyslipidemia drug development
Chong Kun Dang Pharmaceutical said last Monday it has signed an agreement with the state-run Korea Drug Development Fund (KDDF).
The company plans to carry out clinical trials for its dyslipidemia drug candidate as...
Sales inch up but profits plummet at pharmaceutical firms
Korea's listed drug companies witnessed a sales inch up last year from a year earlier, but fell short of reaping more profits than the previous year, data showed Wednesday.
Sales by 50 listed firms rose 1.2 percent...
Small drug makers scramble to survive
Local drug manufacturers are seeking ways to compete abroad as their profits continue to fall in the domestic market after comprehensive price cuts of drugs by the government last April.
Smaller companies are also...
